Effects of Olanzapine on Polydipsia and Intermittent Hyponatremia
J Clin Psychiatry 1997;58:549 [letter]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Letter to the Editor
Sir: The syndrome of polydipsia and intermittent hyponatremia
is a well-documented problem affecting psychotic patients.
Recent studies, however, indicate the treatment with atypical
antipsychotic agents is associated with decreased water consumption
and normalization of serum sodium levels. Olanzapine
recently became available in the United States and is
characterized as a selective monoaminergic antagonist with
high affinity binding to serotonin, dopamine, muscarinic, histamine,
and adrenergic receptors (package insert, 1996).